South Korea Knee Replacement Market Overview, 2031

The South Korean knee replacement industry is shaped by a complex mix of factors, including an aging population, cutting-edge healthcare infrastructure, and increased competition between global leaders and creative local companies. Multinational orthopedic corporations dominate the market because they have great brand equity, large networks of surgeons, and a steady stream of new products. On the other hand, domestic companies and startups are setting themselves apart by offering lower prices, unique implant designs, and digital integration. Entry hurdles are still high because of strict regulatory approvals, clinical validation criteria, and established hospital affiliations. This means that new companies have to rely on strategic partnerships, venture capital funding, and niche technology developments. Mergers and acquisitions have made competition even tougher, giving established companies the chance to grow their portfolios and protect their market share against new business models like patient-specific implants and data-driven surgical solutions. Steady GDP (PPP) growth, significant urbanization, and rising disposable incomes promote continued demand, especially in cities where modern hospitals are more common. Demographic changes, such as the fast aging of the population and higher life expectancy, are making procedures more common. At the same time, the middle class is more prepared to pay for treatments that improve their quality of life. Changes after the pandemic have sped up digital transformation across the value chain, from virtual consultations to data-enabled surgical planning. This is happening even if supply chain problems and rising prices are affecting pricing tactics. The cultural focus on active aging, the high level of trust in medical technology, and the growing acceptance of high-end imported gadgets are all changing what consumers expect and how businesses compete in the market.

According to the research report, "South Korea Knee Replacement Overview, 2031," published by Bonafide Research, the South Korea Knee Replacement is anticipated to grow at more than 6.2% CAGR from 2026 to 2031.Average selling prices (ASP) are determined by reimbursement structures, implant material costs, brand positioning, and technological sophistication in the highly regulated, value-driven knee replacement industry in South Korea. Demand for cutting-edge implants like robotically assisted, minimally invasive, and patient-specific knee systems has helped ASPs rise somewhat in recent years, but public hospitals subject to national insurance reimbursement restrictions continue to be price sensitive. Manufacturers must balance premium and value-based pricing strategies across sales channels as a result of currency volatility and price changes for titanium, cobalt-chromium alloys, and medical-grade polyethylene. Digital platforms are increasingly influencing purchasing decisions through surgeon engagement portals, virtual product demonstrations, and data-driven tendering processes, even though hospital procurement and direct institutional sales still account for the majority of volumes. As a result, digitally enabled sales models are growing more quickly than traditional distributor-led channels. Procedure growth continues to be closely correlated with macroeconomic stability, rising GDP (PPP), high urbanization, and a rapidly aging population, especially in metropolitan areas with sophisticated orthopedic centers and greater disposable expenditures. Affordability is slightly impacted by inflationary pressures, but this is somewhat mitigated by good employment and government healthcare spending. Trade dynamics are important because South Korea benefits from stable trade agreements that reduce the impact of tariffs, but it also depends on imported raw materials and components, mostly from the US, Japan, and Europe. Large multinational corporations have a sizable portion of the market, which has historically grown steadily. However, new market niches including customized implants, outpatient knee replacement options, and technology-integrated systems are gradually driving the market's growth.

The South Korean knee replacement market, which includes total, partial, revision, unicompartmental, patellofemoral, and complex primary surgeries, has changed significantly since 2021, because to regulatory refinement, technical improvement, and altering patient expectations. In recent years, there has been an increase in the use of robotic-assisted surgery, AI-based preoperative planning, and patient-specific equipment, all of which have dramatically improved results for both main and revision procedures. The Ministry of Food and Drug Safety has updated reimbursement guidelines and tightened post-market surveillance, raising compliance standards, increasing documentation, clinical evidence requirements, and certification costs for manufacturers, while also improving patient safety and market transparency. Strategic mergers, distributor consolidations, and technological alliances have increased the global reach of orthopedic leaders while also allowing for portfolio expansion into sophisticated and revision-focused treatments. Post-COVID consumer sentiment supports minimally invasive techniques, shorter recovery times, and long-lasting implant function, resulting in increased demand for partial and unicompartmental treatments among younger, active patients. Although supply chain disruptions impacted alloy sourcing and component availability, regional inventory management and diverse procurement helped to stabilize production. Sustainability issues, such as reduced surgical waste and ecologically friendly production, are increasingly impacting procurement decisions at large hospitals. Geopolitical uncertainty has had a moderate influence on import logistics, highlighting the necessity of regulatory-aligned trade agreements. Looking ahead, expert forecasts predict steady mid-single-digit growth over the next decade, driven by rapid population aging, rising procedure complexity, and ongoing innovation in complex primary and revision knee replacements, while policy evolution, cost containment pressures, and surgeon training requirements continue to be key factors influencing market performance.

The South Korean market for knee replacements is divided into hospitals and surgical centers, ambulatory surgery centers, specialty orthopedic clinics, academic medical centers, outpatient surgical facilities, and multi-specialty healthcare systems. Each of these groups has its own pricing structure, which is affected by things like reimbursement structures, procedure volumes, and buying power. Average selling prices differ a lot between end users. For example, large hospitals and academic centers benefit from bulk purchasing, long-term vendor contracts, and value-based pricing models. On the other hand, specialty clinics and outpatient facilities often have higher per-unit ASPs because they don't have as much negotiating power and lower volumes. Over time, ASPs have stayed quite consistent, with only small increases due to rising costs of raw materials, more people using complex implants, and changes in currency affecting imported parts. Price elasticity stays mild since national health insurance covers demand, but cost sensitivity is more in ambulatory and outpatient settings where efficiency and quick turnover are important. More and more, manufacturers use tiered pricing methods. They provide luxury implants to tertiary hospitals and cost-effective solutions to smaller facilities. Controlled discounts and bundled service packages also influence buying decisions. Following the rules set by the Ministry of Food and Drug Safety, becoming certified, and keeping up with changing regulations about the environment and consumer protection all raise expenses and affect how competitive a company is in different end-user groups. Experts say that all types of care will continue to rise, but outpatient and ambulatory facilities will grow the fastest because of policies that favor shorter hospital stays, more minimally invasive methods, and computerized surgery planning. Revisions to reimbursement, inflationary pressures, and macroeconomic volatility are still important factors that affect pricing stability and long-term growth expectations across the end-user environment.

Over the past 20 years, the South Korean market for knee replacements has changed a lot. It has moved away from standard implant designs and toward highly customized, technology-integrated solutions. This includes implants, surgical instruments, navigation systems, robotic systems, patient-specific instrumentation, and surgical accessories. Tertiary hospitals and academic medical facilities were the first to use the technology. They helped train surgeons and sped up the acceptance of innovative implants and computer-assisted equipment. Product design has slowly moved toward better biocompatibility, longer implant life cycles, and compatibility with minimally invasive procedures. At the same time, navigation and robotic systems have become disruptive technologies that increase the accuracy and consistency of surgery. Pricing dynamics differ significantly among product categories, with implants commanding the highest average selling prices, succeeded by robotic and navigation systems categorized under premium, value-based pricing models. ASPs have gone raised over time because of rising raw material costs, currency rate fluctuations, and bundled technology offers. However, demand elasticity stays mild because of reimbursement support and clinical outcome priorities. Since 2021, the industry has seen more regulatory scrutiny, strategic acquisitions by multinational orthopedic companies, and faster digital change because to AI-enabled planning and data analytics platforms. Supply chain problems made it harder to get some parts for a period, which led to methods for sourcing and optimizing inventory in specific areas. At the same time, environmental concerns are having a bigger impact on how materials are chosen and purchased. Experts say that sustained growth will continue because of the use of robots, patient-specific solutions, and digital ecosystems that connect implants to software platforms. However, changes in policy, the need for capital investment, and uncertainty in the economy will all affect how quickly products are adopted.

Considered in this report
• Historic Year: 2020
• Base year: 2025
• Estimated year: 2026
• Forecast year: 2031

Aspects covered in this report
• South Korea Hip Replacement Market with its value and forecast along with its segments
• Hip Replacement Market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Ask an Expert

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now